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Abstract
The historical town of Weimar in Thuringia, the "green heart of Germany" was the sphere of
Goethe and Schiller, the two most famous representatives of German literature's classic era. Not
yet entirely as influential as those two cultural icons, the Signal Transduction Society (STS) has
nevertheless in the last decade established within the walls of Weimar an annual interdisciplinary
Meeting on "Signal Transduction – Receptors, Mediators and Genes", which is well recognized as
a most attractive opportunity to exchange results and ideas in the field.
The 12th STS Meeting was held from October 28 to 31 and provided a state-of-the-art overview of
various areas of signal transduction research in which progress is fast and discussion lively. This
report is intended to share with the readers of CCS some highlights of the Meeting Workshops
devoted to specific aspects of signal transduction.
The Workshop on Transcription Control in Cells and
Tissues was introduced by a Keynote Presentation of Ker-
stin Krieglstein (University of Freiburg) on "TGF-β signal-
ling in nervous development". Upon giving an overview
on TGF-β receptor and SMAD factor signalling, the
speaker presented experimental evidence on the cross-talk
of TGF-β-mediated signalling cascade with other signal-
ling pathways, such as the MAPK/ERK cascade. These and
other data suggests that TGF-β not only signals through
the SMAD transcription factors but also through a number
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of other signalling pathways which control such funda-
mental events as proliferation, differentiation, migration,
cell death, angiogenesis and wound healing. This leads
often to seemingly opposite experimental outcomes when
various cell types have been treated by TGF-β.
Among the four short presentations of the workshop two
reports dealt with the synthesis and function of NFAT
('Nuclear Factor of Activated T Cell') factors in lymphoid
cells. By analysing the induction conditions of NFATc1 in
primary T cells from human blood, Hanna Bendfeldt and
colleagues (Deutsche Rheumaforschungszentrum, Berlin)
came to the conclusion that the activity of p38 protein
kinase plays an essential role in the autoregulation of
NFATc1 transcription in T cells which is thought to be
controlled by NFATc2 and NF-κB. Inhibition of p38 activ-
ity leads to suppression of NFATc1/A induction, a short
isoform of NFATc1 whose activity supports the survival of
peripheral lymphocytes. In contrast, other NFATc pro-
teins, such as NFATc2 and NFATc1/C (a longer NFATc1
isoform) exert a strong pro-apoptotic activity. As dis-
cussed by Friederike Berberich-Siebelt (University of
Würzburg), both NFATc2 and NFATc1/C are sumoylated
in their C-termini and, thereby, – as shown for NFATc1/C
– are guided to heterochromatic nuclear territories. As a
consequence of sumoylation, these NFAT proteins bind to
histone deacetylases (HDACs) and can act as suppressors
of transcription of interleukin 2 gene and of other genes.
This might play a role for gene expression in regulatory T
(Treg) cells by NFATs which can associate with Foxp3, an
important (or the 'master') regulator of Treg development
and function. By using microarray techniques in studies of
human Treg  cells,  Andrea Tuettenberg and colleagues
(University of Mainz) demonstrated an under-representa-
tion of NFAT factors in nuclei of human Treg cells. These
authors identified Galectin-10 as a Treg-specific protein
whose expression – as shown by siRNA inhibition – con-
tributes to Treg-mediated suppression. As typical for
human Treg cells, the same authors identified by kinome
profiling a NEMO-like protein kinase and a high extent of
STAT5b phosphorylation. Similar to NFATs, NF-κB factors
play a crucial role in the survival of lymphocytes. Dirk
Mielenz and colleagues (University of Erlangen) identi-
fied Tfg (Trk fused gene) as a partner of Carma-1/Ikk-γ, i.e.
of molecules of "canonical" NF-κB signalling cascades.
Upon B cell receptor and CD40 triggering, Tfg appears to
recruit Carma to the plasma membrane, thereby enhanc-
ing the basal and CD40-mediated induced activity of Ikkβ
and NF-κB. Tfg is expressed at highest levels in marginal
zone and B1 B cells suggesting a particular function in NF-
κB activation in these B cell populations.
The Workshop on Receptor-triggered Pathways was
opened by Arne Östman (Karolinska Institute, Stock-
holm), who presented in his keynote presentation recent
achievements in translational science with potential
meaning for cancer treatment. Low molecular weight
inhibitors of receptor tyrosine kinase activity as well as
antibodies blocking the receptors at the extracellular face
are widely used and constitute valuable for fighting can-
cers which rely on constitutive activation or overexpres-
sion of such receptors. These treatments, however, are
only of limited value when downstream signalling mole-
cules are dysregulated with respect to their activity or
expression. New strategies do not only focus on the malig-
nant cells themselves but also on supporting cells express-
ing growth factors with stimulatory effects on cancer cell
proliferation or on angiogenesis. For instance, parakrine
signals emanating from cancer associated fibroblasts act
as growth factors or as chemokines and, thus, stimulate
tumour progression. They may represent novel targets for
pharmaceutical intervention.
One of the most prominent regulators of cell survival is
the Fas ligand. However, Maren Paulsen and colleagues
(University of Kiel) demonstrated CD95-dependent accel-
erated proliferation of TCR/CD3/CD28 activated T-lym-
phocytes by immobilized agonistic FAS antibodies
(reverse signalling). In contrast, neither the soluble pro-
tein nor immobilized FasL exert similar activities. FasL
rather inhibited the proliferation, indicating a negative
reverse signalling capacity of FasL.
Fewer strategies were developed to interfere with down-
stream signalling events relevant for malignant cell
growth. The need to further elucidate signalling mecha-
nisms relevant for the growth control of malignant cells is
obvious. This understanding was reflected by several talks.
As shown by Heike Hermanns (Rudolf Virchow Center
Würzburg), chemokine (CCL1,7,8) expression is rapidly
induced by Oncostatin M (OSM) in primary human der-
mal fibroblasts. Expression appears to depend on activa-
tion of the MAPK cascade. ERK1/2 affects gene expression
whereas p38 affects the half live of CCL mRNA. Although
OSM is a strong activator of STAT 1, 3, and 5, STAT activa-
tion is not crucial for OSM-initiated CCL expression.
Instead, STAT5 activation counteracts CCL1 expression
through the induction of the feedback inhibitor CIS.
The proto-oncogene and adaptor protein Gab2 is associ-
ated with the signal transduction of many growth factors.
This adaptor recruits the VIPs of growth factor signalling,
namely Grb2, SHP2, PI-3 kinase and beside other func-
tions contributes to the initiation of the MAPK cascade.
Tilman Brummer and colleagues (University of New
South Wales, Sydney) set up a proteomics-based study to
define a phosphorylation map of Gab2, and found new
sites phosphorylated by PI-3 kinase. Since these phospho-
rylated motifs are, on the one hand, recognized by 14.3.3
proteins, and binding of 14.3.3 to Gab2, on the otherCell Communication and Signaling 2009, 7:2 http://www.biosignaling.com/content/7/1/2
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hand, terminates signalling through Gab2, this mecha-
nism represents a novel negative feedback mechanism for
the control of growth factor signalling. Interestingly, this
mechanism does not apply for Gab1-mediated signalling.
Henning Urlaub and colleagues (University of Göttin-
gen) applied an in vivo labelling approach to identify
phosphorylation sites in leukocyte adapter protein SLP-
65. Detailed kinetic and functional studies revealed a high
resolution picture of respective roles by individual phos-
phorylation sites within the SLP-65 molecule in activation
of the MAPK cascade and AP-1-mediated gene regulation.
Treatment of solid tumours, especially of the gastrointes-
tinal track is still one major challenge in cancer therapy.
Due to the introduction of new specific inhibitors against
receptor tyrosine kinases and signaling molecules such as
PI-3-kinases or GTPases of the Ras superfamily, the treat-
ment options have made considerable progress. In the
workshop on Tumour Biology and Cancer Therapy Götz
von Wichert (University of Ulm) focussed his keynote
presentation specifically on current concepts and their
limitations in the treatment of gastrointestinal tumours.
He highlighted several new clinical studies addressing the
efficacy of targeting EGF or VEGF receptors. This strategy
occurs to be quite logical with regard to the numerous
data demonstrating the relevance of EGFR and VEGF sig-
nalling in tumour progression. However, several new clin-
ical trials have recently documented significant draw-
backs in the implementation of these in vitro data to clin-
ical trials. For example patients with colorectal cancer
bearing mutations in the k-ras gene might even have a
poorer prognosis under medication with an EGFR inhibi-
tor. In addition, emerging aspects in the understanding of
tumour biology (i.e. circulating tumour cells or tumour
stem cells) challenge a number of the established treat-
ment concepts. Thus, only the precise understanding of
tumour biology will warrant the development of new
treatment strategies, but it will be at the same time one of
the most challenging tasks for the future.
In the following short talks, Susanne Steinert (University
of Jena) presented novel data on the importance of bone
morphogenetic protein BMP-2 as a potential prognostic
marker for human breast cancer. Expression of BMP-2,
which is markedly expressed in small, low-grade breast
tumours, was found positively correlated with Bcl-2, sev-
eral cell cycle regulator proteins and the potential tumour
suppressor SFRP-1. Higher BMP-2 levels, particularly in
nodal-negative invasive breast carcinoma might, thus,
result in a prognostic advantage of these patients.
The impact of the scaffold protein CNK1 on breast carci-
noma cell behaviour was addressed by Rafael D. Fritz and
colleagues (University of Zurich). CNK1 was found to
influence the invasion-promoting machinery by interfer-
ing with the expression of matrix metalloprotease MT1-
MMP via inducible elements and by deregulation of the
NF-κB pathway. Silencing of tumour-relevant molecules
is becoming more and more relevant in analyzing the
functional relevance of individual molecules.
Britta Eiz-Vesper and colleagues (Hannover Medical
School) applied an RNAi-based approach to permanently
silence the expression of the NKG2A/CD94 receptor on
NK and T cells. Targeting of NKG2A resulted in enhanced
lyses of these cells and might improve the success of cell-
based immunotherapeutics.
In the last talk of this session, Stephan M. Feller (Univer-
sity of Oxford) discussed new aspects of the structural
basis of adaptor proteins Grb2 and Gab2 for oncogenic
signalling in tumor cells. Two new atypical SH3 domain
interaction sites were discovered in Gab2 which might be
crucial for the binding of the C-terminal SH3 (SH3C)
domain of Grb2 to Gab2 and, thus, might represent a new
target structure for the generation of SH3C domain spe-
cific inhibitors.
The Workshop Signalling Induced By Pathogens has
established itself as a "traditional" constituent of the STS
Meetings which readily reflects the increasing general
interest in this research field. It is now that we begin to
understand why interaction of microbial pathogens with
the signal transduction network of their target cells is
essential for pathogenesis and biology of infection. Cellu-
lar pathways are now being considered as promising tar-
gets for the development of anti-pathogenic strategies.
This year, presentations on signalling events induced by
bacterial infections outnumbered contributions on viral
signalling, underscoring our increasing knowledge of how
bacteria and their toxins exploit host cell signalling for
their own purposes.
In his keynote lecture, Klaus Aktories (University of
Freiburg) gave an overview on mechanisms by which bac-
terial toxins modify cellular Rho GTPases. As examples for
toxins activating Rho GTPases, the cytotoxic necrotizing
factors (CNFs) of E. coli and Yersinia  species were dis-
cussed, which deamidate a glutamine residue involved in
the switch-off mechanism of the GTPases. Other toxins
such as the Clostridium difficile toxins A and B inactivate
various Rho GTPases by glucosylation. Because Rho
GTPases have critical functions in both innate and adap-
tive immunity, the important role of targeting Rho
GTPases for the biology of bacterial infection was dis-
cussed.
Most notably, bacterial toxins can also act as mitogens
and even induce cell transformation by interacting withCell Communication and Signaling 2009, 7:2 http://www.biosignaling.com/content/7/1/2
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cellular signalling. Katharina F. Kubatzky and colleagues
(University of Heidelberg), demonstrated that the Pas-
teurella multocida toxin (PMT), which causes atrophic
rhinitis in pigs, caused anchorage-independent growth of
epithelial kidney cells. This finding also points to poten-
tial carcinogenic properties of the toxin. Data were pre-
sented demonstrating that PMT stimulates the JAK-STAT
pathway which was even further enhanced after co-expres-
sion of SOCS1. PMT-induced expression of the serine/
threonine kinase Pim1 caused phosphorylation of SOCS1
and, thus, accumulation of JAK2 and enhanced signaling
which might contribute to the transforming capacity of
the bacterial toxin.
Norbert Reiling and colleagues (Research Center Borstel)
found a novel inverse relationship of the Toll-like recep-
tor/NF-κB and the Wnt/β-catenin pathways after aerosol
infection of mice with Mycobacterium tuberculosis, which
may be involved in preserving cell homeostasis during
bacteria-induced inflammation. Initially, Reiling's group
had observed that components of the Wnt/Frizzled path-
way are differentially expressed after infection with myco-
bacteria, especially Frizzled1 being induced on
macrophages in response to M. tuberculosis. During their
further studies, they found that Wnt signaling is involved
in restoring TLR/NF-κB-induced downregulation of β-cat-
enin.
Another highlight of the session was the presentation by
Sina Bartfeld (Max-Planck Institute of Infection Biology,
Berlin). Bartfeld and collegues established an RNA-inter-
ference-based high-throughput assay to identify novel
components of the NF-κB pathway. The assay is based on
a human epithelial cell line stably expressing a p65-GFP
fusion protein whose nuclear translocation can be
detected by automated microscopy. An siRNA library was
cotransfected to screen for proteins required for p65-GFP
translocation in response to various stimuli. Applying this
assay they could identify two proteins that were critical for
NF-κB activation in response to Helicobacter pylori but not
TNF-α or IL1-β. One of the two factors, an E3-ligase, had
not been linked to the NF-κB pathway before and is now
under intense investigation.
Viral proteins that interact with host cellular signalling
were also investigated further. Eike R. Hrincius (Univer-
sity of Münster) presented data demonstrating that the
non-structural protein 1 (NS1) of Influenza A virus binds
to the cellular adaptor proteins Crk and CrkL, tereby
determining the sensitivity of influenza viruses to the
expression of the two adapter proteins. Crk and CrkL
exclusively bind to NS1, if the second SH3 motif of NS1
harbours the protein-sequence PPLPPK, which predomi-
nantly occurs in NS1 of highly virulent avian influenza
virus strains. Binding of NS1 to Crk or CrkL contributes to
the suppression of the antiviral JNK/ATF2 pathway. It was
also shown that virus strains which are able to bind Crk or
CrkL are attenuated upon knockdown of the adapter pro-
teins. Because NS1 is known as a virulence factor whose
sequence variation determines pathogenicity of the virus,
the specific interaction of NS1 variants with cellular
adapter proteins is of great interest to understand the
molecular basis for the severity of highly virulent influ-
enza infections.
In the Workshop on Differentiation, Senescence and
Cell Death, Peter Herrlich (Leibniz Institute for Age
Research/Fritz Lipmann Institute, Jena) focused in his key-
note lecture on the regulation of the GTP-binding protein
p21-Ras and its role in determining cell fate. Whereas Ras
can be activated via growth factor receptors and the adap-
tor proteins Grb2/SOS, signals can be relayed together
with an ERM complex to F-Actin. The ERM complex con-
sists of Ezrin, Radixin and Moesin. Importantly, Ezrin is
also a binding partner for the cytoplasmic part of CD44v6,
a splice variant of the proteoglycan-rich cell adhesion
molecule CD44 which is implicated in cell activation sig-
nalling, invasion and tumour survival. Down-modulation
of CD44 is required for the tumor suppressive activity of
p53. Merlin can counteract the Ezrin-mediated activation
of Ras in the ERM complex. and, thus, balances Ras-medi-
ated downstream signalling, thereby possibly also con-
tributing to tumour-suppression.
Tereza Benesova and colleagues (Institut für umwelt-
medizinische Forschung, Düsseldorf) demonstrated that,
interestingly, the susceptibility of skin cells towards the
infrared A part of natural sunlight is affected by the circa-
dian rhythm. The central role of mitochondrial DNA in
photoaging was underscored by Bianca Schuermann and
colleagues (Düsseldorf), who presented evidence that
increased levels of photo-inducible mtDNA deletions are
functionally relevant for intensified matrix degradation
and are therefore responsible for detrimental changes in
photoaged skin. Aging is also one major risk factor of car-
diovascular diseases and therefore it is important to
understand vascular aging on a cellular level: Here, Buech-
ner et al. found that mitochondrial Telomerase reverse
transcriptase (TERT) has a protective role in mitochondria
by strongly contributing to mtDNA integrity. TERT is asso-
ciated with nuclear SHP-2, which acts as a negative regu-
lator for nuclear export of TERT and reduces the formation
of reactive oxygen species, as reported by Sascha Jakob
and colleagues (Düsseldorf). Thus, nuclear SHP-2 activity
seems to be a major player in the delay vascular aging
processes.
A range of outstanding presentations was experienced by
attendees of the Workshop on Signalling In Immune
Cells. Mark Philips (New York University School of Med-Cell Communication and Signaling 2009, 7:2 http://www.biosignaling.com/content/7/1/2
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icine) kicked off the day with a keynote lecture on the
compartmentalization of Ras signalling in T cells. Using a
combination of CFP-tagged Ras molecules and a YFP-
tagged Ras binding domain (RBD) that specifically targets
active Ras, he nicely showed that in response to anti-CD3
stimulation alone, Ras activation occurred upon the
Golgi, whereas in the presence of costimulation via the
integrin LFA-1, Ras activation occurs at both the plasma
membrane (PM) and Golgi. Additionally, he showed by
using the C1 domain of Protein Kinase C fused to GFP as
a reporter for diacylglycerol (DAG) production, that the
mechanism by which ICAM contributed to DAG produc-
tion requires phospholipase D2.
Stefan Feske (New York University School of Medicine)
presented data from patients with T+B+ severe combine
immunodeficiency (SCID). Lymphocytes from these
patients show only intracellular calcium flux, but no con-
tribution from the extracellular calcium channels, which
led to the discovery of the ORAI and STIM proteins. He
also presented the characterization of single point
mutants for ORAI that indicate the protein oligomerizes
in the membrane to form an ion channel. Additionally,
data were presented for the ER calcium sensors STIM1 and
STIM2 suggesting that sustained calcium flux plays an
important role in cytokine production and the develop-
ment of regulatory T cells.
In a short talk by Claudia Brandt (Deutsches Rheumafor-
schungszentrum, Berlin) data on the benefit of low dose
cyclosporin (CsA) therapy in patients with atopy were pre-
sented. This treatment reduced T cell receptor signalling
and increased the number of regulatory T cells
(CD4+Foxp3+). In investigating the mechanism, the group
suggests that low TCR signalling leads to a low expression
of TGIF, which in turn enhances the effect of TGF-β
thereby promoting Treg development.
Doris Urlaub and colleagues (University of Heidelberg)
used modelling to address the question of how an NK cell
decides whether or not to kill a target cell. A simple model
was created containing the minimal elements, an activat-
ing receptor that acts via a Src kinase to phosphorylate the
substrate, Vav1, and an inhibitory receptor that acts via the
phosphatase Shp-1 to dephosphorylate the substrate. A
key assumption is that Vav1 plays a central role in the
decision making process. Various parameters, such as
receptor clustering, were investigated and compared to the
experimental data. The resulting model has the potential
to provide insights into the integration of positive and
negative signals during lymphocyte activation.
René Eulenfeld (Technical University of Aachen) pre-
sented data on a novel mechanism regulating the recruit-
ment Gab1 to the plasma membrane. Gab1 is an adapter,
consisting of a single pleckstrin homology (PH) domain
and a long 'tail' containing multiple tyrosine residues by
which in recruits RasGAP, PI-3 kinase and Shp-2. In rest-
ing cells, Gab1 is cytosolic, but upon stimulation with
cytokine (+IL-6) it translocates to the PM, where it
becomes phosphorylated. Translocation is dependent on
the PH domain and could be blocked by inhibiting PI-3
kinase activity. Interestingly, the MEK inhibitor U0126
also blocked membrane recruitment of Gab1. Further
analysis identified the ERK-dependent phosphorylation
of Ser551 as a key step regulating the translocation of
Gab1. Thus it appears that Ser551 falls within an autoin-
hibitory domain that regulates the function of the PH
domain.
Another keynote lecture was presented by Ed Clark (Uni-
versity of Washington) on the regulation of B cell entry
into the cell cycle. Data was presented showing that the
adapter Bam32 promotes entry into the cell cycle, while
superoxide has the opposite effect. Both Bam32 and the
NADPH oxidase complex compete for binding of PIP2 and
Rac1, and by doing so may fine-tune signalling within B
cells. Additional data were presented on the role of cas-
pases in regulating the cell cycle. Interestingly, caspase 6-
deficient B cells were prone to differentiate into plasma
cells, rather than proliferate upon stimulation. This
appears to be due to a dysregulation of the cell cycle regu-
lator retinoblastoma (Rb).
Facundo Batista (London Research Institute) presented
data on B cell responses to antigen. Membrane tethered
antigens presented by either follicular dendritic cells
(FDCs) or dendritic cells (DCs) appear to be of particular
importance. Using the DT-40 B cell system, the influence
of a number of signalling molecules on microcluster for-
mation and cell spreading were investigated, as well as the
role of the coreceptor, which appears to be important for
antigens when they are membrane bound, but not in a
soluble form.
Jürgen Wienands (University of Göttingen) investigated
the signalling differences between naive and antigen-
experienced B cells. He characterized a tyrosine-based sig-
nalling motif found within the cytoplasmic tail of the IgG
heavy chain that upon stimulation becomes phosphor-
ylated by Syk and recruits Grb2 to enhanced PLCγ activa-
tion and calcium flux. Thus, this motif appears to play a
costimulatory-like function in B cell receptor signalling.
The DT-40 system was also used by Edgar Serfling and
colleagues (University of Würzburg) who showed that
high levels of NFATc1/alphaA-protected B cells from acti-
vation-induced cell death (AICD) by promoting the tran-
scription of anti-apoptotic molecules such as Bcl-6. Since
NFATc1/alphaA appears to control genes related to affin-Publish with BioMed Central    and   every 
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ity maturation, its expression in germinal center (GC) B
cells was investigated by immunohistochemistry. A strong
nuclear localization was observed in a subset of GC B
cells, which is in striking contrast to the cytosolic staining
observed in most lymphocytes. Since this subset of cells
appeared to express neither IgM nor apoptotic markers, it
was proposed that NFATc1/alpha A contributes to the sur-
vival of mature GC B cells.
Simone Keck (University of Freiburg) presented data on
the role of the Src kinase Lyn in negatively regulating Toll-
like receptor (TLR) signalling in bone marrow-derived
macrophages. Her data showed that macrophages from
Lyn-deficient mice secreted higher levels of proinflamma-
tory cytokines in response to TLR-ligands. She also
observed a complex of Lyn and PI-3 kinase. To test if this
was the mechanism of action, she inhibited PI-3 kinase
with wortmannin and showed that cytokine production
was increased. Additionally, in SHIP1-deficient mice, she
observed a decrease in cytokine production in response to
TLR-stimulation. Thus, she concluded that the negative
regulatory function of Lyn upon cytokine production is at
least in part mediated via PI-3 kinase.
The Workshop on Adhesion, Motility, Morphology
started with a keynote lecture by Harvey McMahon (Med-
ical Research Council, Cambridge) on the various mecha-
nisms of endocytotic processes. He showed that
endocytosis can occur in very different ways. McMahon
especially distinguished endocytotic pathways that
involve the canonical coat protein clathrin, or are inde-
pendent of this protein, defined as pleiomorphic clathrin-
independent carriers (CLICs) and GPI-enriched endocytic
compartments (GEECs). Furthermore, he described the
GTPase activating protein GRAF1 as a key regulator of the
CLIC and GEEC endocytic pathways. The session contin-
ued with a contribution by Cornelia Dietrich from (Uni-
versity of Mainz). She presented data on the regulation
and signalling pathways of the aryl hydrocarbon receptor
(AhR), which is a transcription factor involved in physio-
logical processes as well as toxic responses to 2,3,7,8-tet-
rachlorodibenzo-p-dioxin (TCDD). Treatment of rat liver
oval cells led to induction of the transcription factor JunD,
resulting in transcriptional upregulation of the proto-
oncogene cyclin A which in turn led to a loss of contact
inhibition and increased proliferation of the oval cells.
Lars Müller (University of Kiel) reported on the regula-
tion of cancer-associated fibroblasts (CAFs) under the
influence of the cytokine tumour necrosis factor (TNF)-
alpha. He provided data that this inflammatory activation
of the transcription factor NF-κB in CAFs leads to the
release of interleukin-6, the monocyte-chemotactic pro-
tein-1 and other effects. The release of such inflammatory
factors by CAFs in response to TNF-α promotes chemo-
taxis of colon carcinoma cells towards CAFs and might
provide an explanation for colorectal metastasis forma-
tion in the liver.
Sven Kröning (University of Erlangen), introduced a
novel cell migration assay. He explained artificial surfaces
such as plastic bottoms of culture dishes as one major
problem in the use of two-dimensional migration assay.
He described a new system similar to the traditional
scratch assay: In his experimental setup, the surface is
coated with components of the extracellular matrix. A bar-
rier is introduced in the cell culture, which is removed
after the cell growth has reached confluency to provide a
cell-free space corresponding to the scratch in the conven-
tional scratch assay. The advantage of this procedure is
due to the maintenances of the coated surface during the
"scratch" process. The resulting gap is then closed in a
quantifiable manner by migrating cells.
Conclusion
The 2008 STS meeting clearly showed that signal trans-
duction research has grown from its timid beginnings in
Germany into a vibrant research endeavour that also
attracts a growing number of international colleagues
from many different research areas.
The 2009 conference will be held again in Weimar from
28 to 30 October. The special focus topic for 2009 will be
'The Molecular Biology and Signaling of Ageing'
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